NCT00003397View on ClinicalTrials.gov

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions

Lymphoma

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

rituximab

BIOLOGICAL

sargramostim

DRUG

carmustine

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

dexamethasone

DRUG

etoposide

DRUG

gemcitabine hydrochloride

DRUG

melphalan

DRUG

paclitaxel

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

All Listed Sponsors

collaborator

University of Maryland Greenebaum Cancer Center

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT00003397 - Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter